4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000104
Director sold 1,666 shares at $18.29 ($30,471)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2024-04-15 | Sale 10b5-1 | −1,666 | $18.29 | $30,471 | 118,043 | D |
| Open-market sales · 1,666 sh · avg $18.29 · $30,471 | |||||||
Loading xslF345X05/wk-form4_1713388471.xml…